scholarly journals IDDF2021-ABS-0078 Switching from tenofovir disoproxil fumarate (TDF) and/or other oral antivirals (OAVS) to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with moderate or severe renal impairment, or with end-stage renal disease (ESRD)

Author(s):  
Harry LA Janssen ◽  
Pietro Lampertico ◽  
Chien-Hung Chen ◽  
Jeong Heo ◽  
Claire Fournier ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document